 RANCHO CORDOVA, Calif., March 10, 2021 PRNewswire -- ThermoGenesis Holdings, Inc. Nasdaq: THMO, a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 and provide a corporate strategic update on Wednesday, March 17, 2021, after the close of trading. 